Literature DB >> 11850422

An open conformation of the Thermus thermophilus gyrase B ATP-binding domain.

Valérie Lamour1, Laurence Hoermann, Jean-Marc Jeltsch, Pierre Oudet, Dino Moras.   

Abstract

DNA gyrase forms an A(2)B(2) tetramer involved in DNA replication, repair, recombination, and transcription in which the B subunit catalyzes ATP hydrolysis. The Thermus thermophilus and Escherichia coli gyrases are homologues and present the same catalytic activity. When compared with that of the E. coli 43K-5'-adenylyl-beta,gamma-imidodiphosphate complex, the crystal structure of Gyrase B 43K ATPase domain in complex with novobiocin, one of the most potent inhibitors of gyrase shows large conformational changes of the subdomains within the dimer. The stabilization of loop 98-118 closing the active site through dimeric contacts and interaction with domain 2 allows to observe novobiocin-protein interactions that could not be seen in the 24K-inhibitor complexes. Furthermore, this loop adopts a position which defines an "open" conformation of the active site in absence of ATP, in contrast with the "closed" conformation adopted upon ATP binding. All together, these results indicate how the subdomains may propagate conformational changes from the active site and provide crucial information for the design of more specific inhibitors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11850422     DOI: 10.1074/jbc.M111740200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Structure of the topoisomerase VI-B subunit: implications for type II topoisomerase mechanism and evolution.

Authors:  Kevin D Corbett; James M Berger
Journal:  EMBO J       Date:  2003-01-02       Impact factor: 11.598

2.  Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase.

Authors:  Steven Bellon; Jonathan D Parsons; Yunyi Wei; Koto Hayakawa; Lora L Swenson; Paul S Charifson; Judith A Lippke; Robert Aldape; Christian H Gross
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

3.  Protein modules conserved since LUCA.

Authors:  Yehoshua Sobolevsky; Edward N Trifonov
Journal:  J Mol Evol       Date:  2006-10-29       Impact factor: 2.395

Review 4.  In front of and behind the replication fork: bacterial type IIA topoisomerases.

Authors:  Claudia Sissi; Manlio Palumbo
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

5.  Crystallization and preliminary X-ray crystallographic analysis of DNA gyrase GyrB subunit from Xanthomonas oryzae pv. oryzae.

Authors:  Ha Yun Jung; Ki Jeung Lee; Kyung Ha Kim; Ji Hye Hyoung; Mi Ra Han; Hyun Kyoung Kim; Lin-Woo Kang; Yeh-Jin Ahn; Yong-Seok Heo
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-12-25

6.  Dynamics of strand passage catalyzed by topoisomerase II.

Authors:  Ping Xie
Journal:  Eur Biophys J       Date:  2010-02-03       Impact factor: 1.733

7.  Thermodynamic computational approach to capture molecular recognition in the binding of different inhibitors to the DNA gyrase B subunit from Escherichia coli.

Authors:  Liane Saíz-Urra; Miguel Ángel Cabrera Pérez; Matheus Froeyen
Journal:  J Mol Model       Date:  2013-04-30       Impact factor: 1.810

Review 8.  Topoisomerases as anticancer targets.

Authors:  Justine L Delgado; Chao-Ming Hsieh; Nei-Li Chan; Hiroshi Hiasa
Journal:  Biochem J       Date:  2018-01-23       Impact factor: 3.857

9.  Targeting quinolone- and aminocoumarin-resistant bacteria with new gyramide analogs that inhibit DNA gyrase.

Authors:  Katherine A Hurley; Thiago M A Santos; Molly R Fensterwald; Madhusudan Rajendran; Jared T Moore; Edward I Balmond; Brice J Blahnik; Katherine C Faulkner; Marie H Foss; Victoria A Heinrich; Matthew G Lammers; Lucas C Moore; Gregory D Reynolds; Galen P Shearn-Nance; Brian A Stearns; Zi W Yao; Jared T Shaw; Douglas B Weibel
Journal:  Medchemcomm       Date:  2017-02-27       Impact factor: 3.597

10.  Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187.

Authors:  Scott Classen; Stephane Olland; James M Berger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.